BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Oct 15, 2025; 17(10): 109450
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.109450
Table 1 Comparison of baseline characteristics, pathological types, lactate dehydrogenase levels, complications, and treatment regimens between the focal segmental and extensive groups, n (%)
Somatotype
Focal segmental type (n = 15)
Extensive type (n = 13)
Sex
Boy12 (80)12 (92.3)
Girl3 (20)1 (7.7)
Age (year)8.237.38
Case classification
Burkitt lymphoma8 (53.3)10 (76.9)
Other types of B-cell lymphoma4 (26.7)3 (23.1)
Other types of lymphoma3 (20)0 (0)
LDH
Increase6 (40)13 (100)
Normal9 (60)0 (0)
Median (IU/L)300935
Complication
Intussusception8 (53.3)2 (15.4)
Peritoneal dropsy12 (92.3)13 (100)
Therapeutic method
Surgery5 (33.3)0 (0)
Surgery + chemotherapy4 (26.7)2 (15.4)
Chemotherapy6 (40)11 (84.6)
Prognosis
Cured12 (80)4 (30.8)
Not cured/death3 (20)9 (69.2)
Table 2 Correlation among ultrasound typing, characteristics, pathological types, lactate dehydrogenase levels, complications, treatment regimens and prognosis, n (%)
SomatotypePrognosis
P value
Cured (n = 16)
Not cured/death (n = 12)
Ultrasonic typing0.009
Focal segmental type12 (75)3 (25)
Extensive type4 (25)9 (75)
Sex0.436
Boy13 (81.25)11 (91.7)
Girl3 (18.75)1 (8.3)
Age (year)7.657.380.634
Case classification0.378
Burkitt lymphoma10 (62.5)8(66.7)
Other types of B-cell lymphoma3 (18.78)4(33.3)
Other types of lymphoma3 (18.75)0 (0)
LDH0.002
Increase7 (43.75)12 (100)
Normal9 (56.25)0 (0)
Median (IU/L)3011127
Complications0.397
Intussusception3 (18.75)0 (0)
Peritoneal dropsy9 (56.25)9 (75)
Intussusception + peritoneal dropsy4 (25)3 (25)
Therapy method0.160
Surgery4 (25)1 (8.3)
Surgery + chemotherapy4 (25)2 (16.7)
Chemotherapy8 (50)9 (75)